Jul 5, 20233 min readHealthSyngene to acquire multi-modal facility from Stelis Biopharma Ltd, adding 20,000 litres of installedSyngene (or the “Company”) today announced the acquisition of Unit 3 biologics manufacturing facility in Bangalore, India, from Stelis...